Focuses on cellular models and pathway-level analyses to interrogate neurodegeneration and aging, supporting mechanism discovery and rapid preclinical screening. Integrates molecular biology, neurobiology, and biopharmaceutics to translate findings into candidates and biomarkers for CNS therapeutics.